The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990.
D002648:Child; D004274:DNA, Recombinant; D026724:Ethical Review; D004989:Ethics; D035082:Federal Government; D015316:Genetic Therapy; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D007153:Immunologic Deficiency Syndromes; D008722:Methods; D009316:National Institutes of Health (U.S.); D018579:Patient Selection; D012015:Reference Standards; D012107:Research Design; D035842:Research Subjects; D012926:Social Control, Formal; D014481:United States
Biomedical and Behavioral Research; Genetics and Reproduction; Human Gene Therapy Subcommittee; National Institutes of Health; Points to Consider: Transfer of Recombinant DNA into Human Subjects